Literature DB >> 31359135

[Young male patient with unusual space-occupying lesion of the lower eyelid].

Alexander C Rokohl1, Heike Löser2, Joel M Mor3, Niklas Loreck3, Konrad R Koch3, Ludwig M Heindl3,4.   

Abstract

BACKGROUND: A space-occupying lesion of the eyelid in young adults is often a sign of an inflammation, a trauma or a benign neoplasm. The aim of this case report is to demonstrate a rare basal cell carcinoma, which presumably already arose in adolescence without further high-risk factors.
METHODS: A 28-year-old male patient presented for a second opinion on a painless swelling of the right lower eyelid. According to the patient's history the swelling had been present since the age of 16 years and originally resembled a molluscum contagiosum. An ophthalmologist in private practice made the diagnosis of a suspected trichoepithelioma. The extended patient history revealed a blood coagulation disorder. The clinical ophthalmological examination revealed a nodular space-occupying lesion with a border wall and telangiectasia. The further ophthalmological examination was bilaterally inconspicuous. Due to the suspicion of a malignant process, an operation was promptly carried out using local anesthesia with complete tumor excision and pedicled flap plasty as well as a histopathological investigation to confirm the diagnosis.
RESULTS: The histopathological investigation revealed underlying infiltrates of a basaloid tumor with bale-shaped trabecular growth, sometimes with peripheral palisading of the cells. The cells were predominantly monomorphic with isolated pleomorphic nuclei and sometimes enclosed mitoses. Immunohistochemically the cells were strongly positive for BerEP4 and negative for epithelial membrane antigen (EMA). The diagnosis of a nodular basal cell carcinoma of the right lower eyelid was made. All incision margins were free of tumor cells (R0 resection). In the dermatological screening no further manifestations were detected.
CONCLUSION: Despite the occurrence of a space-occupying lesion of the eyelid in a young adult patient and also with no further risk factors, in addition to an inflammatory event and a benign tumor, a malignant disease, such as a basal cell carcinoma should also be taken into consideration. A tissue biopsy or complete excision with subsequent histological examination including an immunohistochemical analysis are essential for differentiation from other tumor entities.

Entities:  

Mesh:

Year:  2020        PMID: 31359135     DOI: 10.1007/s00347-019-00948-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  18 in total

1.  A young military pilot presents with a periocular Basal Cell Carcinoma: a case report.

Authors:  Stephen D Woolley; Charlotte Hughes
Journal:  Travel Med Infect Dis       Date:  2013-10-30       Impact factor: 6.211

Review 2.  [Therapy options for malignant eyelid tumors].

Authors:  M Weiling; A Bergua; F E Kruse; L Holbach
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059

3.  External irradiation of epithelial skin cancer.

Authors:  R D Lovett; C A Perez; S J Shapiro; D M Garcia
Journal:  Int J Radiat Oncol Biol Phys       Date:  1990-08       Impact factor: 7.038

4.  [Predictors of recurrent basalioma of the eyelids and periorbital region].

Authors:  A C Zimmermann; V Klauss
Journal:  Ophthalmologe       Date:  2001-06       Impact factor: 1.059

Review 5.  Basal cell carcinoma in children: report of 3 cases.

Authors:  B W LeSueur; N G Silvis; R C Hansen
Journal:  Arch Dermatol       Date:  2000-03

Review 6.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

7.  Basal-cell carcinoma of the lower lid in a 27-month-old child.

Authors:  D C Keramidas; D Anagnostou
Journal:  Z Kinderchir       Date:  1987-08

8.  [Advanced periocular basal cell carcinoma-a therapeutic challenge].

Authors:  B Lauterbach; V Kakkassery; D Debus; L M Heindl; E S Schultz
Journal:  Ophthalmologe       Date:  2019-03       Impact factor: 1.059

9.  [SOP - Standarized procedures in diagnostics and therapies of periocular basal cell carcinoma].

Authors:  Vinodh Kakkassery; Ludwig M Heindl
Journal:  Klin Monbl Augenheilkd       Date:  2017-10-09       Impact factor: 0.700

Review 10.  S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 1: Epidemiology, Genetics and Diagnosis.

Authors:  Berenice M Lang; Panagiotis Balermpas; Andrea Bauer; Andreas Blum; G Felix Brölsch; Thomas Dirschka; Markus Follmann; Jorge Frank; Bernhard Frerich; Klaus Fritz; Axel Hauschild; Ludwig M Heindl; Hans-Peter Howaldt; Stephan Ihrler; Vinodh Kakkassery; Bernhard Klumpp; Albrecht Krause-Bergmann; Christoph Löser; Markus Meissner; Michael M Sachse; Max Schlaak; Michael P Schön; Lutz Tischendorf; Michael Tronnier; Dirk Vordermark; Julia Welzel; Michael Weichenthal; Susanne Wiegand; Roland Kaufmann; Stephan Grabbe
Journal:  J Dtsch Dermatol Ges       Date:  2018-12-28       Impact factor: 5.584

View more
  4 in total

Review 1.  [Surgical resection with ophthalmoplastic reconstruction : Gold standard in periocular basal cell carcinoma].

Authors:  A C Rokohl; A Kopecky; Y Guo; V Kakkassery; J M Mor; N Loreck; K R Koch; L M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

Review 2.  [Alternative treatment options for periorbital basal cell carcinoma].

Authors:  Vinodh Kakkassery; Steffen Emmert; Irenäus A Adamietz; György Kovács; Anselm M Jünemann; Caroline Otte; Michael Zimbelmann; Anton Brosig; Salvatore Grisanti; Ludwig M Heindl
Journal:  Ophthalmologe       Date:  2020-02       Impact factor: 1.059

3.  Effective treatment of locally advanced periocular basal cell carcinoma with oral hedgehog pathway inhibitor?

Authors:  Xiaoyi Hou; Alexander C Rokohl; Monika Ortmann; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-09       Impact factor: 3.117

4.  Effective systemic treatment of advanced periocular basal cell carcinoma with sonidegib.

Authors:  Alexander C Rokohl; Ludwig M Heindl
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-02       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.